VistaGen Therapeutics

VistaGen Therapeutics

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$138
$1,476
$465
$303
Gross Profit
-55
1,279
465
114
EBITDA
-10,744
-12,833
-16,527
-18,710
EBIT
-10,937
-13,030
-16,717
-18,899
Net Income
-10,740
-13,030
-16,274
-18,899
Net Change In Cash
138
1,476
465
303
Free Cash Flow
-12,163
-14,707
-16,200
-17,571
Cash
10,892
16,991
30,789
47,371
Basic Shares
44,440
42,980
39,620
42,234

Annual Financials

Values in thousands2026-03-312025-03-312024-03-312023-03-31
Revenue
$1,269
$486
$1,064
$-227
Gross Profit
1,269
486
1,064
-227
EBITDA
-71,393
-50,776
-28,790
-58,736
EBIT
-72,126
-51,411
-29,358
-59,268
Net Income
-69,685
-51,418
-29,362
-59,247
Net Change In Cash
1,269
486
1,064
-227
Free Cash Flow
-66,587
-42,288
-25,874
-49,927
Cash
30,789
67,131
119,166
16,638
Basic Shares
38,073
30,877
19,354
6,958

Earnings Calls

QuarterEPS
2026-09-30
-$0.24
2026-06-30
-$0.30
2026-03-31
-$0.37
2025-12-31
-$0.45